STOCK TITAN

Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

LAVAL, Quebec, July 27, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter financial results on Tuesday, Aug. 9, 2022. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call. 

Conference Call Details

Date:

Tuesday, Aug. 9, 2022



Time:

8:00 a.m. ET



Webcast: 

http://ir.bauschhealth.com/events-and-presentations  



Participant Event Dial-in: 

+1 (888) 317-6003 (United States)

+1 (412) 317-0088 (International)

+1 (866) 284-3684 (Canada) 



Participant Passcode:

10163321



Replay Dial-in:

+1 (877) 344-7529 (United States)

+1 (412) 317-0088 (International)

+1 (855) 669-9658 (Canada)



Replay Passcode:

9325022 (replay available until Aug. 16, 2022) 

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our approximately 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Investor Contact:                             

Media Contact:

Christina Cheng                                 

Kevin Wiggins

ir@bauschhealth.com                     

corporate.communications@bauschhealth.com 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-companies-inc-will-release-second-quarter-2022-financial-results-on-aug-9-301594842.html

SOURCE Bausch Health Companies Inc.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

2.33B
303.99M
0.91%
79.62%
6.14%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
QUEBEC

About BHC

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###